>> Saturday
>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Tuesday 07 July 2026
08:30 - 09:30
Session 34: The power of ultrasound in adenomyosis and endometriosis assessment
Tuesday 07 July 2026
08:30 - 09:30: Session 34: The power of ultrasound in adenomyosis and endometriosis assessment:
Umberto Leone Roberti Maggiore, Italy
08:30 - 08:50
Keep calm and preserve fertility: harnessing the power of ultrasound in differential diagnosis between endometriosis and cancer
09:00 - 09:20
Adenomyosis and deep endometriosis-related infertility: ultrasound is a powerful tool for the clinician
08:30 - 09:30
Session 35: Debate: AI assisted ovarian stimulation
08:30 - 09:30: Session 35: Debate: AI assisted ovarian stimulation:
Frank J. Broekmans, The Netherlands
Sesh Kamal Sunkara, United Kingdom
08:30 - 08:45
Robots will be in control
Nikolaos P. Polyzos, Spain
08:45 - 09:00
Humans will be in control
Taghride Dahhan, The Netherlands
Nikolaos P. Polyzos, Spain
Taghride Dahhan, The Netherlands
08:30 - 09:30
Session 36: Segmental aneuploidies in PGT-A
08:30 - 09:30: Session 36: Segmental aneuploidies in PGT-A:
Efthymia Constantinou, Cyprus
Sioban Sengupta, United Kingdom
08:30 - 08:50
Prevalence and transfer outcomes of segmental aneuploidies
09:00 - 09:20
Managing embryos with segmental aneuploidy: key considerations for patient counseling
08:30 - 09:30
Session 37: Shaping the future of reproductive health: from tradition to science fiction
08:30 - 09:30: Session 37: Shaping the future of reproductive health: from tradition to science fiction:
María Isabel Acien, Spain
08:30 - 08:50
Reproduction in space! How far are we?
Varsha Jain, United Kingdom
09:00 - 09:20
Uterus transplantation versus artificial uterus
08:30 - 09:00
Session 38: ISAR/IFS exchange session: The how and Y of male infertility
08:30 - 09:00: Session 38: ISAR/IFS exchange session: The how and Y of male infertility:
Nandita Palshetkar, India
08:30 - 08:40
Sperm DNA fragmentation
08:45 - 08:55
Role of antioxidants in OAT
09:00 - 09:10
Azoospermia: current advances and the road ahead
Sunita Tandulwadkar, India
09:15 - 09:25
Aphrodite criteria
08:30 - 09:30
Session 39: AMH testing: pathway to empowerment or cause for confusion?
08:30 - 09:30: Session 39: AMH testing: pathway to empowerment or cause for confusion?:
Chairperson to be announced
08:30 - 08:50
Role, benefits, and risks of AMH testing for ART & non-ART related indications
09:00 - 09:20
Marketing empowerment: How corporations co-opt feminist narratives to promote non-evidence-based use of the anti-Mullerian hormone test
08:30 - 09:30
Session 40: Poster discussion session - Embryology
08:30 - 09:30: Session 40: Poster discussion session - Embryology:
08:30 - 08:40
Beyond Single Morphological Metrics: Integrating Oocyte Diameter and Artificial Intelligence-Based Scoring Improves Prediction of Developmental Competence and Implantation
Elaine Pasamba, Philippines
08:40 - 08:50
Blastocyst developmental characteristics following in vitro maturation of MI oocytes versus in vivo–matured MII oocytes: a retrospective multicenter study
Clara Perez de Blas, Spain
08:50 - 09:00
Late bloomers or wasted costs? The cost-effectiveness of day7-blastocysts in ICSI–PGT-A cycles.
09:00 - 09:10
Granulosa cell ASPM expression as a novel non-invasive biomarker for oocyte meiotic spindle integrity and maturation competence in human assisted reproduction
09:10 - 09:20
Organelle-scale 3D holotomography reveals reproducible subcellular organisation patterns in embryos and oocytes for translational in vitro fertilisation applications
Chungha Lee, Korea, South
09:20 - 09:30
Comparison of ultra-shortened oocyte warming protocols: an interventional study on survival and parthenogenetic activation outcomes
09:00 - 12:00
Practising embryo transfer techniques using a virtual reality-based simulator - Hands-on course only for those participants registered for this course
09:00 - 12:00: Practising embryo transfer techniques using a virtual reality-based simulator - Hands-on course only for those participants registered for this course:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
09:30 - 10:30
Besins Healthcare: Progesterone in Early Pregnancy: Current Evidence and Future Research Horizons
09:30 - 10:30: Besins Healthcare: Progesterone in Early Pregnancy: Current Evidence and Future Research Horizons:
09:30 - 09:35
Opening remarks
09:35 - 09:55
Luteal phase defect and reproductive outcomes: current evidence and research priorities
Pedro Melo, United Kingdom
09:55 - 10:15
Comparisons of luteal support from real world evidence and future directions
Tom Bamford, United Kingdom
10:25 - 10:30
Closing remarks
10:00 - 11:30
Session 41: AI-Powered embryology
10:00 - 11:30: Session 41: AI-Powered embryology:
Hannah Newby, United Kingdom
10:00 - 10:15
Can free-access general-purpose AI platforms reliably predict IVF outcomes? A benchmarking study of image-based embryo interpretation against live-birth results
10:15 - 10:30
Artificial intelligence-based prediction of developmental competence in rescued metaphase II oocytes derived from germinal vesicle and metaphase I stages
10:30 - 10:45
Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in 1,770 PGT-A blastocysts
Juanjo Fraire-Zamora, Spain
10:45 - 11:00
ROSE, an artificial intelligence (AI) supported workflow system for optimizing donor oocyte management, reduces chances of complete blastulation failure compared with random lot assignment
11:00 - 11:15
A real-time predictive alert system for monitoring IVF laboratory performance using time-lapse–derived embryo features.
11:15 - 11:30
Conventional morphological grading and AI blastocyst assessment: Prevalence of grading discordance and analysis of pregnancy rates
10:00 - 11:30
Session 42: Low response: any light at the end of the tunnel?
10:00 - 11:30: Session 42: Low response: any light at the end of the tunnel?:
Kirsten Louise Tryde Macklon, Denmark
Ying C. Cheong, United Kingdom
10:00 - 10:15
RANKL and OPG are age-dependent novel regulators of ovarian folliculogenesis
10:15 - 10:30
In vitro fertilization versus conversion to intrauterine insemination in poor ovarian responders: an open-label, randomized, multicentre, non-inferiority trial
Pierre-Emmanuel Bouet, France
10:30 - 10:45
Does stimulation protocol determine optimal trigger strategy? A multicenter RCT comparing sequential double versus simultaneous dual trigger in POSEIDON group 3-4 poor ovarian responders.
10:45 - 11:00
Endometriosis and ovarian reserve: a cohort study
11:00 - 11:15
Intraovarian platelet-rich plasma does not improve embryo quality or ovarian response in women with diminished ovarian reserve: a randomised controlled trial.
11:15 - 11:30
Progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in intracytoplasmic sperm injection cycles in patients with diminished ovarian reserve: a prospective randomized study
10:00 - 13:00
Session 43: Live surgery session
10:00 - 13:00: Session 43: Live surgery session:
María Isabel Acien, Spain
Angelos Daniilidis, Greece
Tubal reanastomosis with robot
DIE and endometriotic cystectomy and/or anterior discoid rectal
Laparoscopic isthmocele repair
Filipa Beja Osorio, Portugal
Laparoscopic dermoid cyst
Carla Tomassetti, Belgium
Laproscopic uterine malformation repair/DIE
Stavros Karampelas, Greece
Isthmocele mini resectoscope
Myomectomy with resectoscope
Part 4: Hysteroscopic surgery
Polypectomy shaver surgeons
Aschermann syndrome bettocchi
Aschermann syndrome bettocchi
Aschermann syndrome bettocchi
10:00 - 11:30
Session 44: Immunology, microbiota and omic analyses in implantation and early pregnancy
10:00 - 11:30: Session 44: Immunology, microbiota and omic analyses in implantation and early pregnancy:
Roy G Farquharson, United Kingdom
10:00 - 10:15
Tacrolimus improves pregnancy rates after euploid blastocyst transfer in RIF/RPL patients with low regulatory T cells levels.
10:15 - 10:30
A multi-omics-derived blood biomarker panel for early pregnancy loss diagnosis and prediction: a multi-centre study
10:30 - 10:45
Characterization of the transcriptomic cargo of uterine fluid extracellular vesicles during the window of implantation according to pregnancy outcome, a prospective cohort study with validation
10:45 - 11:00
The dynamics of peripheral blood neutrophils during implantation with and without immunomodulation
Caroline Nørgaard-Pedersen, Denmark
11:00 - 11:15
An emerging hypothesis: the endometrial environment as a key determinant of frozen embryo implantation success
11:15 - 11:30
Dysbiosis-associated gut and seminal microbiomes are linked to impaired pregnancy establishment and increased pregnancy loss
ida Behrendt-Møller, Denmark
10:00 - 11:30
Session 45: The PGT-A story starts at the biopsy
10:00 - 11:30: Session 45: The PGT-A story starts at the biopsy:
Ioannis Sfontouris, Greece
Amy Barrie, United Kingdom
10:00 - 10:15
Preimplantation genetic testing for aneuploidy in POSEIDON Group 4: benefit or harm?
10:15 - 10:30
Clinical relevance of high-level mosaicism after PGT-A: mosaic segmental aneuploidies drive unexpected live birth outcomes
Francesca Spinella, Italy
10:30 - 10:45
The outcomes of assisted reproductive technology with preimplantation genetic testing for aneuploidy in women aged 40 and older using their own oocytes.
Yousef Alhelou, United Arab Emirates
10:45 - 11:00
Trophectoderm biopsy for preimplantation genetic testing (PGT) on unhatched blastocyst-stage embryos versus blastocysts that are hatching or hatched from the zona pellucida: does it matter?
11:00 - 11:15
Precise time to trophectoderm biopsy predicts ploidy and euploid embryo outcomes: a continuous analysis using operator-independent radiofrequency identification witnessing
Andreu Quintana-Vehi, Spain
11:15 - 11:30
Same quality, different timing: Do Day 6 and Day 5 euploid embryos with equivalent morphology have comparable reproductive potential?
Aline R. Lorenzon, Brazil
10:00 - 11:30
Session 46: Endometrial preparation to frozen embryo transfer under the spotlight
10:00 - 11:30: Session 46: Endometrial preparation to frozen embryo transfer under the spotlight:
10:00 - 10:15
Exposure to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in frozen embryo transfers leads to improved pregnancy outcomes in autologous cycles: a retrospective cohort analysis
Maria De Los Llanos Medrano, Spain
10:15 - 10:30
Modified natural-cycle frozen embryo transfer provides comparable pregnancy outcomes with fewer obstetric complications than artificial cycles in women 40 and over years old.
10:30 - 10:45
Determinants of live birth and perinatal outcomes after single euploid embryo transfer: a multivariable analysis of 2,599 cycles
10:45 - 11:00
Transcriptomic and genomic insights into cellular contributions during in vitro model of human implantation
11:00 - 11:15
Association between endometrial pattern and reproductive outcomes in donor oocyte cycles: a multicentric retrospective analysis on 14,039 single embryo transfers
11:15 - 11:30
Impact of pre-transfer serum progesterone fluctuation on implantation in single euploid Hormonal-Replacement-Therapy Frozen Embryo Transfer (HRT-FET) cycles.
Suzan Samir, United Arab Emirates
10:00 - 11:30
Session 47: Poster discussion session - Andrology
10:00 - 11:30: Session 47: Poster discussion session - Andrology:
Chairperson to be announced
10:00 - 10:10
Systemic delivery of protein-adsorbing testis-targeting lipid nanoparticles can improve sperm parameters and rescue fertility in Cep112 KO mouse model
10:10 - 10:20
Quantitative assessment of sperm–oocyte binding capacity (IZUMO1–JUNO) predicts fertilization rate in IVF cycles with unexplained infertility
10:20 - 10:30
Revisiting the role of sperm DNA fragmentation in assisted reproductive technologies: an updated systematic review and meta-analysis
10:30 - 10:40
An entirely in vitro model to generate functional male neogametes
10:40 - 10:50
Hyperspectral Sperm Imaging Guides Machine-Learning–based Prioritisation of Spermatozoa Associated with Top-Quality Blastocyst Development
Rosa María Pacheco-Rendón, Spain
10:50 - 11:00
Becoming a father after 40: a question of experience rather than risk
11:00 - 11:10
Do seminal white blood cells influence sperm parameters and oxidative stress measures? Results from a large cohort study
11:10 - 11:20
Sperm DNA integrity and chromatin structure as determinants of PLCζ activity in male infertility
11:20 - 11:30
Evaluating X-linked conditions in male preconception screening: a retrospective study of expanded carrier screening in sperm donors
11:45 - 13:00
Gedeon Richter:“Are We Overtreating Women When the Issue Lies with Men?”
11:45 - 13:00: Gedeon Richter:“Are We Overtreating Women When the Issue Lies with Men?”:
11:45 - 11:50
Introduction
11:50 - 12:10
The hidden burden: when women carry the treatment load for male infertility
12:10 - 12:30
Looking ahead: paternal age and its impact on offspring health
Darren Griffin, United Kingdom
12:30 - 12:50
Male infertility in 2031: evolving challenges, emerging solutions and predictions
Chris Barratt, United Kingdom
11:45 - 12:45
Session 48: European and Global ART monitoring
11:45 - 12:45: Session 48: European and Global ART monitoring:
Chairperson to be announced
11:45 - 12:15
Assisted Reproductive Technology (ART) in Europe 2024 and development of a strategy of vigilance: preliminary results generated from European registers by the ESHRE EIM consortium
Diane De Neubourg, Belgium
12:15 - 12:30
ICMART Preliminary world report, 2022
12:30 - 12:45
The international glossary on infertility and fertility care, 2025
Fernando Zegers-Hochschild, Chile
11:45 - 12:45
Session 49: Navigating the cold zone: from microfluidics to faster protocols
11:45 - 12:45: Session 49: Navigating the cold zone: from microfluidics to faster protocols:
Rod Mitchell, United Kingdom
11:45 - 12:05
Microfluidics to find all your eggs and cryopreserve them during a retrieval
12:15 - 12:35
Shorter protocols for vitrification and post-warming dilution of human oocytes and embryos: experience, learnings and outcomes
Miguel Gallardo, Portugal
11:45 - 12:45
Session 50: Engaging the next generation of digital-native patients
11:45 - 12:45: Session 50: Engaging the next generation of digital-native patients:
Dinka Pavicic Baldani, Croatia
Rami Wakim, United Kingdom
11:45 - 12:05
Healthtech in fertility care: personalising treatment for the digital age – meeting the expectations of digitally savvy patients
Julie Morgan, United Kingdom
12:15 - 12:35
Preconditions to parenthood: changes over time and generations
11:45 - 12:45
Session 51: Optimising care in non-obstructive azoospermia
11:45 - 12:45: Session 51: Optimising care in non-obstructive azoospermia:
Joris Veltman, United Kingdom
11:45 - 12:00
Recovering sperm from clinically negative microTESE specimens using an AI-enabled microwell platform
12:00 - 12:15
ACMG/AMP-guided discovery of regulatory CLPP and GPX4 risk variants in non-obstructive azoospermia with concordant testicular transcript–protein depletion
12:15 - 12:30
A simple assay to spare azoospermic men from an unnecessary testicular biopsy
12:30 - 12:45
Testicular sperm aspiration in men with high DNA fragmentation index (DFI): a retrospective analysis of ICSI pregnancy outcomes
14:30 - 15:15
Merck: Metformin & pregnancy: Focus on Diabetes and PCOS
14:30 - 15:15: Merck: Metformin & pregnancy: Focus on Diabetes and PCOS:
14:30 - 14:32
Welcome and introduction
14:32 - 14:52
Metformin in pregnancies complicated by type 2 diabetes - where do we stand now?
Christine Newman, Ireland
14:52 - 15:12
Metformin for ovulation induction in women with PCOS/PMOS
15:12 - 15:15
Summary and closeout
11:45 - 12:45
Session 52: Poster discussion session - Endometriosis and Endometrial Disorders
11:45 - 12:45: Session 52: Poster discussion session - Endometriosis and Endometrial Disorders:
11:45 - 11:55
Endometriosis and Risk of Autoimmune Diseases: Evidence from a Nationwide Korean Cohort
11:55 - 12:05
Multi-omics human/microbial atlas of chronic endometritis reveals microbial signatures and host immune responses
Alberto Sola-Leyva, Sweden
12:15 - 12:25
Platelet-derived mitochondrial transplantation promotes tissue regeneration by suppressing M1 macrophage polarization in a rat model of endometriosis
12:25 - 12:35
Randomized controlled study of an anti-inflammatory diet on in vitro fertilization outcomes in women with endometriosis (DANTE study): preliminary results
12:35 - 12:45
Endometrial motile cilia and fertility: structural and functional investigation using multimodal imaging in tissue and organoid models
Ella Proudley, United Kingdom
12:45 - 13:45
BSV: The Fertility Continuum: Horizon 2030 Reimagining the infertility journey — From foundational protocols to global consortia
12:45 - 13:45: BSV: The Fertility Continuum: Horizon 2030 Reimagining the infertility journey — From foundational protocols to global consortia:
12:45 - 12:55
Retrospective: art of ivf
12:55 - 13:10
Clinical excellence: the science of ivf
12:55 - 13:10
Clinical excellence: the science of ivf
Yulia Koloda, Russia C.I.S.
13:10 - 13:35
Future readiness: the ecosystem of ivf
Yulia Koloda, Russia C.I.S.
13:10 - 13:35
Future readiness: the ecosystem of ivf
13:10 - 13:35
Future readiness: the ecosystem of ivf
13:35 - 13:45
Questions from audience
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:15
IBSA Institut Biochimique SA: Tackling fertility decline in a changing society
14:00 - 15:15: IBSA Institut Biochimique SA: Tackling fertility decline in a changing society:
14:00 - 14:05
Welcome address
14:00 - 14:05
Welcome address
Richard Anderson, United Kingdom
14:05 - 14:20
Why aren’t women having babies anymore?
Jacky Boivin, United Kingdom
14:20 - 14:35
Fertility awareness: the new family planning
Joyce Harper, United Kingdom
14:35 - 14:50
Is elective fertility preservation really effective or missing the point?
Nikolaos P. Polyzos, Spain
14:50 - 15:05
Management options to maximize success in the face of age
Ernesto Bosch Aparicio, Spain
15:05 - 15:15
Take home messages
15:05 - 15:15
Take home messages
Richard Anderson, United Kingdom
14:00 - 15:15
Session 53: MHR symposium
14:00 - 15:15: Session 53: MHR symposium:
14:00 - 14:20
New insights into oocyte meiosis with therapeutic implications
14:30 - 14:50
Chromosomal chaos: modeling aneuploidy in primate embryogenesis
14:00 - 15:00
Session 54: ASPIRE exchange session: Enhancing fertility outcome
14:00 - 15:00: Session 54: ASPIRE exchange session: Enhancing fertility outcome:
Chairperson to be announced
Chii-Ruey Tzeng, Taiwan R.O.C.
14:00 - 14:20
Up-to-date treatment of adenomyosis
14:30 - 14:50
Underrecognized genome-wide uniparental disomy and triploidy in human blastocysts revealed by a concurrent preimplantation genetic testing method
Richard Choy Kwong Wai, Hong Kong
14:00 - 15:00
Session 55: Andrological predictors of healthy pregnancies with live births
14:00 - 15:00: Session 55: Andrological predictors of healthy pregnancies with live births:
Chairperson to be announced
Chairperson to be announced
14:00 - 14:20
Clinical and ultrasound andrological parameters predictive for a pregnancy with a live birth
14:30 - 14:50
Genomics in reproductive health: diagnosing male infertility and predicting the success of medical assisted reproduction
Joris Veltman, United Kingdom
14:00 - 15:00
Session 56: Patient session:Fertility@Work: navigating infertility in the workplace
14:00 - 15:00: Session 56: Patient session:Fertility@Work: navigating infertility in the workplace:
Maciej Śmiechowski, Poland
14:00 - 14:15
Cycling from work: normalizing infertility treatments in employment contracts
Laura Sgureva-Cox, Finland
14:20 - 14:35
Fertility is not a private matter!
Mie Marie Brøggler, Denmark
14:40 - 14:55
Hitting the limits: when fertility treatment and work collide
14:00 - 15:00
Session 57: How to address the healthcare professionals (HCP) concerns and difficulties?
14:00 - 15:00: Session 57: How to address the healthcare professionals (HCP) concerns and difficulties?:
Cathy Herbrand, United Kingdom
14:00 - 14:20
Which are the difficulties of the HCP in ART in dealing with patients?
14:30 - 14:50
How can psychologists help/support the HCP team in ART?
14:00 - 15:00
Session 58: Poster discussion session - Reproductive genetics
14:00 - 15:00: Session 58: Poster discussion session - Reproductive genetics:
14:00 - 14:10
Individual chromosome gains and losses show differing rates of maternal inheritance; a study of aneuploidy origin following PGT-A testing of 23,500 embryo biopsies
Kristine McWilliams, U.S.A.
14:10 - 14:20
High-precision reconstruction of structural variations via one-step integrated analysis based on 3D genome
Alejandro Llorente Álvarez, Spain
14:20 - 14:30
Beyond motility: ciliary dyskinesia–related rare genetic variants in couples with recurrent fertilization failure after ICSI
14:30 - 14:40
Chromosome-specific pregnancy outcomes after mosaic embryo transfer: disentangling abnormality severity from chromosome identity
Sun-Nyoung Hwang, Korea, South
14:40 - 14:50
Clinical utility and efficiency of abnormally fertilized oocytes derived blastocysts in PGT-M cycles
14:50 - 15:00
Optimal Timing of NIPT in IVF Vanishing Twin Pregnancies: A Retrospective Analysis of Fetal Heartbeat vs. Gestational Sac Only Groups
Jei Won Moon, Korea, South
15:15 - 16:30
Session 59: The clock is ticking in the embryology lab
15:15 - 16:30: Session 59: The clock is ticking in the embryology lab:
Gemma Arroyo Cardona, Spain
Chairperson to be announced
15:15 - 15:30
Timing matters: the warming–ICSI interval influences oocyte viability and blastocyst yield in a multicentre study on 3,291 vitrified donor oocytes.
Francesca Lolicato, Spain
15:30 - 15:45
The oocyte retrieval-to-denudation interval independently predicts euploid blastocyst yield in PGT-A cycles: a retrospective cohort study of 1,502 cycles
15:45 - 16:00
Day-after rescue ICSI: is it an effective strategy to overcome total fertilisation failure?
Orhun Isikoglu, United Kingdom
16:00 - 16:15
From atypical fertilization to last-chance success: the real clinical value of 1PN-embryos in IVF
16:15 - 16:30
The clinical utilisation of atypically fertilised embryos: counselling patients when presented with 2.1PN, full 3PN or 4PN or more embryos on day 1 of culture
Leighann Nesbeth, United Kingdom
15:15 - 16:30
Session 60: Innovative protocols: new solutions for old problems?
15:15 - 16:30: Session 60: Innovative protocols: new solutions for old problems?:
Yacoub Khalaf, United Kingdom
15:15 - 15:30
The 2-shot protocol: a randomised controlled trial of a novel two-injection ovarian stimulation strategy
15:30 - 15:45
Low anti-müllerian hormone (AMH) levels measured by high-sensitivity ELISA in premature ovarian insufficiency (POI): detection of AMH spikes and correlation with oocyte retrieval (retrospective study)
15:45 - 16:00
Time to reappraise IVF stimulation in PCOS patients? Significantly improved results with GnRH antagonist administration from day 1: a randomised, controlled, double-blinded, pilot trial
Biswanath Ghosh Dastidar, India
16:00 - 16:15
Should we modify ovarian stimulation? Within-patient modifications and their impact on oocyte yield in subsequent cryopreservation cycles: a retrospective cohort study
16:15 - 16:30
Repurposing aminophylline to improve pregnancy outcomes in POSEIDON group 4 patients undergoing assisted reproductive technology: evidence from a cohort study and follicular microenvironment profiling
15:15 - 16:30
Session 61: Internal and external determinants of male reproductive health
15:15 - 16:30: Session 61: Internal and external determinants of male reproductive health:
Chairperson to be announced
15:15 - 15:30
Associations between healthy and unhealthy dietary patterns and testicular function: a comprehensive analysis of individual food groups
Albert Salas-Huetos, Spain
15:30 - 15:45
Temporal trends in total and free testosterone (1972-2019): a systematic review and meta-trend analysis
15:45 - 16:00
Exposure to air pollution mixtures during spermatogenesis and sperm DNA methylation in men seeking infertility treatment
16:00 - 16:15
Does male lifestyle influence geographical differences in sperm parameters?
Rocio Nunez - Calonge, Spain
16:15 - 16:30
Predictive factors for Intrauterine insemination success: A 5-year analysis of 5000+ cycles and multivariable determinants of pregnancy outcomes
15:15 - 16:30
Session 62: Endometriosis and adenomyosis in IVF: predictors, endometrial environment, and reproductive outcomes
15:15 - 16:30: Session 62: Endometriosis and adenomyosis in IVF: predictors, endometrial environment, and reproductive outcomes:
Krina Zondervan, United Kingdom
15:15 - 15:30
Clinical predictors of adenomyosis comorbidity in PCOS IVF patients: endocrine profiling integrated with ACMG/AMP host-variant interpretation
15:30 - 15:45
Impact of adenomyosis on in vitro fertilisation outcomes in women undergoing frozen embryo transfers: a prospective observational study
15:45 - 16:00
Endometrial microbiome and endometritis testing: who is it for?
Efstathios Theodorou, United Kingdom
16:00 - 16:15
Dienogest-based progestin-primed ovarian stimulation versus GnRH antagonist in IVF: a preliminary comparative cohort study
16:15 - 16:30
The presence of ovarian endometrioma adversely affect the IVF/ ICSI outcomes: a multicenter propensity score–matched study
15:15 - 16:30
Session 63: Pre-clinical developments for optimizing fertility preservation strategies
15:15 - 16:30: Session 63: Pre-clinical developments for optimizing fertility preservation strategies:
Stine Gry Kristensen, Denmark
Ephia Yasmin, United Kingdom
15:15 - 15:30
Realising the therapeutic potential of in vitro-grown oocytes from preantral follicles for fertility restoration
Helen M. Picton, United Kingdom
15:30 - 15:45
Everolimus preserves xenotransplanted human ovarian tissue by inhibiting primordial follicle activation via the mTOR/S6/eIF4B signaling pathway
15:45 - 16:00
PI3K/Akt signaling and DNA repair pathways determine stage-dependent follicle responses under genotoxic stress
Luciana Cacciottola, France
16:00 - 16:15
O‑GlcNAcylation-mediated FOXL2 destabilization underlies reduced estrogen synthesis via CYP19A1 in vitrified ovarian tissue
16:15 - 16:30
Molecular signatures of human oocytes: enhanced transcriptomic stability following ultra-rapid vitrification compared with conventional protocols in an expanded cohort
15:15 - 16:30
Session 64: The cost of creation: economics, policy and access to ART
15:15 - 16:30: Session 64: The cost of creation: economics, policy and access to ART:
Denisa Marina Protopopescu, Romania
Lucy van de Wiel, United Kingdom
15:15 - 15:30
Cost-to-baby as a percentage of median household income predicts population-level access to assisted reproductive technology (ART): a global health economics analysis of affordability
Stephanie Kuku, United Kingdom
15:30 - 15:45
Geographical disparities in first assisted reproductive technology treatment in a dual public-private healthcare system – a national register-based study in Denmark 2007-2018
Mie Mølgaard Andersen, Denmark
15:45 - 16:00
Abortion policy and maternal mortality: comparative analysis of Europe and the United States
16:00 - 16:15
Global needs assessment of structured fertility education for healthcare providers
Henry Agortey, United Kingdom
16:15 - 16:30
Assisted reproduction as a pronatalist vehicle to mitigate fertility decline: Europe versus Asia.
15:15 - 16:25
Session 65: Poster discussion session - Implantation and early pregnancy
15:15 - 16:25: Session 65: Poster discussion session - Implantation and early pregnancy:
Linda Stevens Brentjens, The Netherlands
15:15 - 15:25
Letrozole versus hormone replacement therapy for frozen embryo transfer in women with PCOS: a systematic review and meta-analysis of randomized controlled trials (RCTs)
15:25 - 15:35
SPON2-driven activated fibroblasts establish a hyper-adhesive cesarean scar niche permissive to embryo attachment
15:35 - 15:45
Optimising endometrial preparation in women with thin endometrium undergoing Frozen embryo transfer (FET)?
15:45 - 15:55
Progesterone vaginal gel monotherapy versus combined regimen for luteal support in HRT-FET: equivalent pregnancy outcomes but differential predictive utility of serum progesterone
15:55 - 16:05
Endometrial microbiota diversity and pregnancy outcomes in women with reproductive failure or infertility: a systematic review and meta-analysis
Evangelia Deligeoroglou, Greece
16:05 - 16:15
Recipient age and IVF outcomes: an analysis of 2594 donor oocyte recipient cycles
Niyati Sodani, United Kingdom
16:15 - 16:25
LAMB3 at the maternal-fetal interface: Association with endoglandular trophoblast invasion and progesterone-dependent regulation
16:30 - 17:00
Coffee break
16:30 - 17:00: Coffee break:
17:00 - 18:00
Session 66: Cryo reimagined: today's protocols, tomorrow's science
17:00 - 18:00: Session 66: Cryo reimagined: today's protocols, tomorrow's science:
Karan Vadher, United Kingdom
17:00 - 17:15
Defining the optimal number of vitrified donor oocytes to maximise cumulative live birth rates in oocyte donation programmes
17:15 - 17:30
One-step warming of autologous vitrified oocytes versus fresh sibling and conventional warming: AI-based morphological assessment and clinical outcomes
17:30 - 17:45
Ultra-fast warming improves blastocyst development in vitrified oocytes: a monocenter study
Shira Yaacobi-Artzi, Israel
17:45 - 18:00
Developmental competence of vitrified–warmed enucleated oocytes supports the feasibility of using a bank of cryopreserved cytoplasts for maternal spindle transfer in a mouse model
17:00 - 18:00
Session 67: FET strategies in 2026
17:00 - 18:00: Session 67: FET strategies in 2026:
Chairperson to be announced
17:00 - 17:15
Comparative effectiveness of endometrial preparation strategies for frozen embryo transfer: a network meta-analysis of live birth, clinical pregnancy, and miscarriage outcomes
Mikaiel Shuaib, United Kingdom
17:15 - 17:30
Do serum progesterone levels on embryo transfer day predict live birth in true natural cycle frozen embryo transfer cycles?
17:30 - 17:45
Midluteal serum progesterone pharmacokinetics across exogenous luteal support regimens versus the true natural cycle: a randomized clinical trial
17:45 - 18:00
Route and dose-dependent differences in endometrial progesterone and cortisone intracrinology between natural and artificial cycles: a secondary analysis of a randomized clinical trial
17:00 - 18:00
Session 68: Information needs and psychosocial experience of donor families
17:00 - 18:00: Session 68: Information needs and psychosocial experience of donor families:
Mariana Moura-Ramos, Portugal
Valerie Peddie, United Kingdom
17:00 - 17:15
Beyond medical treatment: identifying critical gaps in psychosocial support and information provision for donor conception recipients - survey of 1,103 respondents
Rebecca Kearns, United Kingdom
17:15 - 17:30
Reducing treatment discontinuation between first and second IVF attempts: the value of a multicycle approach
17:30 - 17:45
Navigating donor siblings: multifaceted parental concerns about emotional impact, unknown numbers, and information gaps in global family limits - survey of 1,103 recipients
Hayley King, United Kingdom
17:45 - 18:00
Egg-sharing in the UK: Psychological attitudes, motivations and lived experiences of donors and recipients
Tia Hunjan, United Kingdom
17:00 - 18:00
Session 69: Professional responsibility, patient perspectives and proportionality in ART: ethical and legal dimensions
17:00 - 18:00: Session 69: Professional responsibility, patient perspectives and proportionality in ART: ethical and legal dimensions:
Nicola Williams, United Kingdom
17:00 - 17:15
Governing proportionally to developmental probabilities: Potential problems for human embryos and human stem cell-based embryo models (SCBEMs)
Ana Pereira Daoud, The Netherlands
17:15 - 17:30
Liability for experimental ART innovations: determining responsibility between clinicians, institutions, and device manufacturers under evolving treatment standards.
Sampford Tom, United Kingdom
17:30 - 17:45
Balancing patient autonomy and professional responsibility through ethical deliberation in assisted reproduction
17:45 - 18:00
Reclaiming possibility: patient perspectives on transferring embryos labeled “abnormal” by PGT-A and the ethical and legal implications
Shizuko Takahashi, Singapore Rep. of
17:00 - 18:00
Session 70: The role of surgery in the treatment of infertility associated with endometriosis
17:00 - 18:00: Session 70: The role of surgery in the treatment of infertility associated with endometriosis:
Attila Vereczkey, Hungary
Chairperson to be announced
17:00 - 17:15
IVF outcomes after transvaginal sclerotherapy for ovarian endometrioma versus expectant management: a systematic review and meta-analysis
17:15 - 17:30
Natural orifice specimen extraction improves perioperative outcomes in deep endometriosis and benign colorectal diseases
17:30 - 17:45
Impact of vasopressin-assisted endometriotic cystectomy on ovarian reserve and reproductive outcomes: a 5-year retrospective cohort study.
Jayakrishnan Krishnapillai, India
17:45 - 18:00
Reproductive outcomes after hysteroscopic treatment of adenomyosis in infertile patients undergoing IVF
17:00 - 18:00
Session 71: Poster discussion session - Stem Cells
17:00 - 18:00: Session 71: Poster discussion session - Stem Cells:
João Pedro Alves Lopes, Sweden
17:00 - 17:10
Human umbilical cord perivascular cells (HUCPVC) improve fertility in aged mice and modulate ovarian aging pathways identified by single cell and bulk transcriptomics
17:10 - 17:20
Recreating the functional human ovarian niche: biomimetic hybrid hydrogels for fertility restoration
17:20 - 17:30
Difference in the effects of single Y gene knockouts and Y chromosome loss between mice and humans
Kenta Murakami, United Kingdom
17:30 - 17:40
Does intraovarian combination therapy with exosomes and platelet-rich plasma (PRP) improve IVF outcomes in women with Diminished Ovarian Reserve?
17:40 - 17:50
Human blastoids enabled a scalable and multi-readout platform for the identification of early embryo development regulators
Julieta Sara Del Valle, Austria
17:50 - 18:00
Development of a 3D human endometrium in vitro model using menstrual blood–derived cells
Jonna van den Berg, The Netherlands
16:00 - 17:00
Gufic Biosciences Limited: ART Success Redefined: Implantation to Live Birth
16:00 - 17:00: Gufic Biosciences Limited: ART Success Redefined: Implantation to Live Birth:
16:00 - 16:20
Optimizing ovarian stimulation with hmg: efficacy and safety data comparison with puregraf vs humog vs menotas in patient undergoing art
Nandita Palshetkar, India
16:21 - 16:40
Basics of implantation immunology
14:41 - 15:00
Thymosin as a imuno-modulator in RIF & RPL
18:00 - 19:00
Annual General Assembly
18:00 - 19:00: Annual General Assembly:
08:00 - 12:30
By invitation only - IFFS Committee meeting
08:00 - 12:30: By invitation only - IFFS Committee meeting:
09:00 - 09:45
By invitation only - ICMART-ESHRE Leadership meeting
09:00 - 09:45: By invitation only - ICMART-ESHRE Leadership meeting:
09:00 - 11:00
By invitation only - Fertility Europe meeting
09:00 - 11:00: By invitation only - Fertility Europe meeting:
09:00 - 11:00
By invitation only - EIM Steering Ctt meeting
09:00 - 11:00: By invitation only - EIM Steering Ctt meeting:
09:00 - 11:00
By invitation only - ESHRE GPR on expended carrier screening meeting
09:00 - 11:00: By invitation only - ESHRE GPR on expended carrier screening meeting:
09:30 - 10:30
By invitation only - EU-ARTNet meeting
09:30 - 10:30: By invitation only - EU-ARTNet meeting:
09:30 - 11:30
By invitation only - ORCHID-Net meeting
09:30 - 11:30: By invitation only - ORCHID-Net meeting:
12:00 - 13:00
By invitation only - FeRGI Steering Committee meeting
12:00 - 13:00: By invitation only - FeRGI Steering Committee meeting:
12:00 - 14:00
By invitation only - Human Reproduction Open Associate Editors' meeting
12:00 - 14:00: By invitation only - Human Reproduction Open Associate Editors' meeting:
12:00 - 14:00
By invitation only - Human Reproduction Update Associate Editors' meeting
12:00 - 14:00: By invitation only - Human Reproduction Update Associate Editors' meeting:
12:00 - 14:00
By invitation only - NMCC meeting
12:00 - 14:00: By invitation only - NMCC meeting:
12:30 - 13:30
By invitation only - Ovarian Stimulation Guideline meeting
12:30 - 13:30: By invitation only - Ovarian Stimulation Guideline meeting:
13:00 - 14:00
By invitation only - EuMAR meeting with professionals
13:00 - 14:00: By invitation only - EuMAR meeting with professionals:
13:00 - 14:00
By invitation only - ESHRE Ethics Committee meeting
13:00 - 14:00: By invitation only - ESHRE Ethics Committee meeting:
13:00 - 14:00
By invitation only - FeRGI meeting
13:00 - 14:00: By invitation only - FeRGI meeting:
13:00 - 16:00
By invitation only - EIM Consortium General Assembly meeting
13:00 - 16:00: By invitation only - EIM Consortium General Assembly meeting:
13:30 - 14:30
By invitation only - ESHRE/CARM Liaison Committee meeting
13:30 - 14:30: By invitation only - ESHRE/CARM Liaison Committee meeting:
14:30 - 15:30
By invitation only - ESHRE-IFFS Leadership meeting
14:30 - 15:30: By invitation only - ESHRE-IFFS Leadership meeting:
15:30 - 16:30
By invitation only - ESHRE-ASPIRE Leadership meeting
15:30 - 16:30: By invitation only - ESHRE-ASPIRE Leadership meeting:
14:30 - 18:30
By invitation only - ICMART Contributors meeting
14:30 - 18:30: By invitation only - ICMART Contributors meeting:
15:30 - 17:30
By invitation only - Frozen embryo transfer guideline meeting
15:30 - 17:30: By invitation only - Frozen embryo transfer guideline meeting:
10:00 - 17:00
By invitation only - In vitro models discussion SIG Reproductive Genetics, SIG Implantation and Early Pregnancy, SIG Stem Cells and SIG Ethics and Law
10:00 - 17:00: By invitation only - In vitro models discussion SIG Reproductive Genetics, SIG Implantation and Early Pregnancy, SIG Stem Cells and SIG Ethics and Law:
17:00 - 18:00
By invitation only - SIG Fertility Preservation Steering Ctt meeting
17:00 - 18:00: By invitation only - SIG Fertility Preservation Steering Ctt meeting: